149 related articles for article (PubMed ID: 32502990)
1. Predicting tumor-specific survival in patients with spinal metastatic renal cell carcinoma: which scoring system is most accurate?
Massaad E; Hadzipasic M; Alvarez-Breckenridge C; Kiapour A; Fatima N; Schwab JH; Saylor P; Oh K; Schoenfeld AJ; Shankar GM; Shin JH
J Neurosurg Spine; 2020 Jun; 33(4):529-539. PubMed ID: 32502990
[TBL] [Abstract][Full Text] [Related]
2. Predicting survival for metastatic spine disease: a comparison of nine scoring systems.
Ahmed AK; Goodwin CR; Heravi A; Kim R; Abu-Bonsrah N; Sankey E; Kerekes D; De la Garza Ramos R; Schwab J; Sciubba DM
Spine J; 2018 Oct; 18(10):1804-1814. PubMed ID: 29567516
[TBL] [Abstract][Full Text] [Related]
3. Validation of Traditional Prognosis Scoring Systems and Skeletal Oncology Research Group Nomogram for Predicting Survival of Spinal Metastasis Patients Undergoing Surgery.
Chanplakorn P; Budsayavilaimas C; Jaipanya P; Kraiwattanapong C; Keorochana G; Leelapattana P; Lertudomphonwanit T
Clin Orthop Surg; 2022 Dec; 14(4):548-556. PubMed ID: 36518924
[TBL] [Abstract][Full Text] [Related]
4. Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.
Huang CC; Peng KP; Hsieh HC; Groot OQ; Yen HK; Tsai CC; Karhade AV; Lin YP; Kao YT; Yang JJ; Dai SH; Huang CC; Chen CW; Yen MH; Xiao FR; Lin WH; Verlaan JJ; Schwab JH; Hsu FM; Wong T; Yang RS; Yang SH; Hu MH
Clin Orthop Relat Res; 2023 Jun; 482(1):143-57. PubMed ID: 37306629
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of different scoring systems for spinal metastases based on a Chinese cohort.
Li Z; Guo L; Guo B; Zhang P; Wang J; Wang X; Yao W
Cancer Med; 2023 Feb; 12(4):4125-4136. PubMed ID: 36128836
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparison of the accuracy of the New England Spinal Metastasis Score (NESMS) to legacy scoring systems in prognosticating outcomes following treatment of spinal metastases.
Schoenfeld AJ; Ferrone ML; Blucher JA; Agaronnik N; Nguyen L; Tobert DG; Balboni TA; Schwab JH; Shin JH; Sciubba DM; Harris MB
Spine J; 2022 Jan; 22(1):39-48. PubMed ID: 33741509
[TBL] [Abstract][Full Text] [Related]
7. Comparing the Accuracy of Seven Scoring Systems in Predicting Survival of Lung Cancer Patients With Spinal Metastases: An External Validation From Two Centers.
Yan Y; Zhong G; Lai H; Huang C; Yao M; Zhou M; Zhou C; Wang J; Cheng S; Zhang Y
Spine (Phila Pa 1976); 2023 Jul; 48(14):1009-1016. PubMed ID: 37350732
[TBL] [Abstract][Full Text] [Related]
8. The SORG nomogram accurately predicts 3- and 12-months survival for operable spine metastatic disease: External validation.
Paulino Pereira NR; Mclaughlin L; Janssen SJ; van Dijk CN; Bramer JAM; Laufer I; Bilsky MH; Schwab JH
J Surg Oncol; 2017 Jun; 115(8):1019-1027. PubMed ID: 28346699
[TBL] [Abstract][Full Text] [Related]
9. Assessing the Performance of Prognostic Scores in Patients with Spinal Metastases from Lung Cancer Undergoing Non-surgical Treatment.
Truong VT; Al-Shakfa F; Roberge D; Masucci GL; Tran TPY; Dib R; Yuh SJ; Wang Z
Asian Spine J; 2023 Aug; 17(4):739-749. PubMed ID: 37408290
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of Prognostic Models to Facilitate Surgical Decision-Making for Patients With Spinal Metastatic Disease.
Wick JB; Kalistratova VS; Jr DP; Fine JR; Boozé ZL; Holland J; Vander Voort W; Hisatomi LA; Villegas A; Conry K; Ortega B; Javidan Y; Roberto RF; Klineberg EO; Le HV
Spine (Phila Pa 1976); 2023 Apr; 48(8):567-576. PubMed ID: 36799724
[TBL] [Abstract][Full Text] [Related]
12. Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?
Pan YT; Lin YP; Yen HK; Yen HH; Huang CC; Hsieh HC; Janssen S; Hu MH; Lin WH; Groot OQ
Clin Orthop Relat Res; 2024 Mar; ():. PubMed ID: 38517402
[TBL] [Abstract][Full Text] [Related]
13. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and its predictive value in patients with metastatic spinal cancer.
Gao QP; Yang DZ; Yuan ZB; Guo YX
World J Clin Cases; 2021 Jul; 9(20):5470-5478. PubMed ID: 34307601
[TBL] [Abstract][Full Text] [Related]
15. Surgical Efficacy and Prognosis of 54 Cases of Spinal Metastases from Breast Cancer.
Weitao Y; Zhihuang L; Liangyu G; Limin N; Min Y; Xiaohui N
World Neurosurg; 2022 Sep; 165():e373-e379. PubMed ID: 35750145
[TBL] [Abstract][Full Text] [Related]
16. International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.
Tseng TE; Lee CC; Yen HK; Groot OQ; Hou CH; Lin SY; Bongers MER; Hu MH; Karhade AV; Ko JC; Lai YH; Yang JJ; Verlaan JJ; Yang RS; Schwab JH; Lin WH
Clin Orthop Relat Res; 2022 Feb; 480(2):367-378. PubMed ID: 34491920
[TBL] [Abstract][Full Text] [Related]
17. Does the SORG Machine-learning Algorithm for Extremity Metastases Generalize to a Contemporary Cohort of Patients? Temporal Validation From 2016 to 2020.
de Groot TM; Ramsey D; Groot OQ; Fourman M; Karhade AV; Twining PK; Berner EA; Fenn BP; Collins AK; Raskin K; Lozano S; Newman E; Ferrone M; Doornberg JN; Schwab JH
Clin Orthop Relat Res; 2023 Dec; 481(12):2419-2430. PubMed ID: 37229565
[TBL] [Abstract][Full Text] [Related]
18. Analysis of seven prognostic scores in patients with surgically treated epidural metastatic spine disease.
Westermann L; Olivier AC; Samel C; Eysel P; Herren C; Sircar K; Zarghooni K
Acta Neurochir (Wien); 2020 Jan; 162(1):109-119. PubMed ID: 31781995
[TBL] [Abstract][Full Text] [Related]
19. Decreased psoas muscle area is a prognosticator for 90-day and 1-year survival in patients undergoing surgical treatment for spinal metastasis.
Hu MH; Yen HK; Chen IH; Wu CH; Chen CW; Yang JJ; Wang ZY; Yen MH; Yang SH; Lin WH
Clin Nutr; 2022 Mar; 41(3):620-629. PubMed ID: 35124469
[TBL] [Abstract][Full Text] [Related]
20. Assessing the utility of a prognostication model to predict 1-year mortality in patients undergoing radiation therapy for spinal metastases.
Shi DD; Chen YH; Lam TC; Leonard D; Balboni TA; Schoenfeld A; Skamene S; Cagney DN; Chi JH; Cho CH; Harris M; Ferrone ML; Hertan LM
Spine J; 2018 Jun; 18(6):935-940. PubMed ID: 29031992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
